- Last edited on February 19, 2022
Differences
This shows you the differences between two versions of the page.
cl:wernicke-korsakoff [on September 25, 2018] |
cl:wernicke-korsakoff [on February 19, 2022] psychdb [Thiamine Storage] |
||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ====== Wernicke Encephalopathy and Korsakoff Syndrome ====== | ||
+ | {{INLINETOC}} | ||
+ | |||
+ | ===== Primer ===== | ||
+ | **Wernicke-Korsakoff Syndrome** (WKS) is a neuropsychiatric syndrome caused by thiamine (vitamin B1) deficiency, commonly found in chronic alcoholism. This primarily alcohol-induced disorder is characterized by amnesia, confabulation, disorientation, and neurological findings. WKS occurs due to necrotic lesions to the mammillary bodies, thalamus, and brainstem. The syndrome itself consists of 2 components: **Wernicke encephalopathy (WE)**, and **Korsakoff’s amnesia (KA)**, hence the combined name **Wernicke-Korsakoff Syndrome**. | ||
+ | |||
+ | == History == | ||
+ | <alert type="info" icon="fa fa-book fa-lg fa-fw"> | ||
+ | See also: **[[https://pubmed.ncbi.nlm.nih.gov/23157990/|Isenberg-Grzeda, E. et al. (2012). Wernicke-Korsakoff-syndrome: under-recognized and under-treated. Psychosomatics, 53(6), 507-516.]]** | ||
+ | </alert> | ||
+ | |||
+ | |||
+ | == Epidemiology == | ||
+ | * The prevalence is estimated to be up to 2% among the general population and as high as 12.5% in patients with alcohol use disorders.[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979979/|Isenberg-Grzeda, E., Alici, Y., Hatzoglou, V., Nelson, C., & Breitbart, W. (2016). Nonalcoholic thiamine-related encephalopathy (Wernicke-Korsakoff syndrome) among inpatients with cancer: a series of 18 cases. Psychosomatics, 57(1), 71-81.]])] | ||
+ | * Autopsy studies indicate that Wernicke is frequently undiagnosed during life, and is first diagnosed postmortem in over 80% of case.[([[https://pubmed.ncbi.nlm.nih.gov/20642790/|Galvin, R., Bråthen, G., Ivashynka, A., Hillbom, M., Tanasescu, R., & Leone, M. A. (2010). EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European Journal of Neurology, 17(12), 1408-1418.]])][([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578911/|Flynn, A., Macaluso, M., D’Empaire, I., & Troutman, M. M. (2015). Wernicke’s encephalopathy: increasing clinician awareness of this serious, enigmatic, yet treatable disease. The primary care companion for CNS disorders, 17(3). | ||
+ | ]])] | ||
+ | |||
+ | == Prognosis == | ||
+ | * Wernicke encephalopathy is an acute presentation that when identified and treated in a timely manner, can lead to quick improvement of symptoms. | ||
+ | * Failure to diagnose and treat Wernicke encephalopathy can result in death in up to 20% of patients | ||
+ | * If untreated, up to 75% may develop Korsakoff syndrome (irreversible cognitive impairment), and the chance of full recovery is low[([[https://www.cmaj.ca/content/186/8/E295|Day, G. S., & Del Campo, C. M. (2014). Wernicke encephalopathy: a medical emergency. Cmaj, 186(8), E295-E295.]])] (but not impossible[([[https://pubmed.ncbi.nlm.nih.gov/15746545/|Carota, A., & Schnider, A. (2005). Dramatic recovery from prolonged Wernicke-Korsakoff disease. European neurology, 53(1), 45-46.]])]). | ||
+ | * Wernicke-Korsakoff syndrome thus is sometimes referred to as alcoholic dementia or alcohol-related dementia. | ||
+ | |||
+ | == Comorbidity == | ||
+ | * [[addictions:alcohol:1-use-disorder|Alcohol use disorder]] is highly common. | ||
+ | * In industrialized countries, 90% of the cases of thiamine deficiency are associated with alcohol use disorder.[([[https://pubmed.ncbi.nlm.nih.gov/16384871/|Thomson, A. D., & Marshall, E. J. (2006). The natural history and pathophysiology of Wernicke's encephalopathy and Korsakoff's psychosis. Alcohol and Alcoholism, 41(2), 151-158.]])] | ||
+ | * However! This is not a disease that affects only alcohol users, most cases of missed WKS are in those without an alcohol misuse history. | ||
+ | * Thiamine deficiency also presents in several syndromes other than Wernicke’s encephalopathy, including cardiac beriberi, neuropathic beriberi. | ||
+ | |||
+ | == Risk Factors == | ||
+ | * [[addictions:alcohol:1-use-disorder|Alcohol use disorder]], cancer patients,[([[https://pubmed.ncbi.nlm.nih.gov/23157990/|Isenberg-Grzeda, E., Kutner, H. E., & Nicolson, S. E. (2012). Wernicke-Korsakoff-syndrome: under-recognized and under-treated. Psychosomatics, 53(6), 507–516.]])] gastrointestinal surgery (e.g. - bariatric, gastric bypass), hyperemesis gravidarum, and starvation/fasting are risk factors.[([[https://pubmed.ncbi.nlm.nih.gov/20642790/|Galvin, R., Bråthen, G., Ivashynka, A., Hillbom, M., Tanasescu, R., & Leone, M. A. (2010). EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European Journal of Neurology, 17(12), 1408-1418.]])] | ||
+ | |||
+ | ===== Underdiagnosis ===== | ||
+ | * Wernicke encephalopathy may be overlooked in 68% of patients with alcoholism and 94% of patients without alcoholism (e.g. - cancer patients).[([[https://www.cmaj.ca/content/186/8/E295|Day, G. S., & Del Campo, C. M. (2014). Wernicke encephalopathy: a medical emergency. Cmaj, 186(8), E295-E295.]])][([[https://pubmed.ncbi.nlm.nih.gov/23157990/|Isenberg-Grzeda, E., Kutner, H. E., & Nicolson, S. E. (2012). Wernicke-Korsakoff-syndrome: under-recognized and under-treated. Psychosomatics, 53(6), 507–516.]])] | ||
+ | |||
+ | ===== Diagnosis ===== | ||
+ | WKS is a clinical diagnosis. Although often described as a triad (oculomotor abnormalities, cerebellar dysfunction, and an altered mental state) in the classic literature, it is rare for all three clinical signs to be present. [([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979979/|Caine, D., Halliday, G. M., Kril, J. J., & Harper, C. (1997). Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. Journal of Neurology, Neurosurgery & Psychiatry, 62(1), 51-60.]])] Less than 16% of individuals with WKS will have all three signs. Neuroimaging findings may help in confirming the diagnosis but it is not diagnostic. | ||
+ | |||
+ | ==== Caine Criteria ==== | ||
+ | In 1997, Caine et al. proposed that a diagnosis can be made when patients have any ''2'' of the following 4 features:[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC486695/|Caine, D., Halliday, G. M., Kril, J. J., & Harper, C. (1997). Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. Journal of Neurology, Neurosurgery & Psychiatry, 62(1), 51-60.]])] | ||
+ | - Nutritional deficiency | ||
+ | - Ocular signs | ||
+ | - Cerebellar signs | ||
+ | - Altered mental status or mild memory impairment | ||
+ | |||
+ | ==== Signs and Symptoms ==== | ||
+ | * A dramatic improvement of neurologic signs often indicates adequate treatment and confirms the clinical diagnosis of Wernicke encephalopathy.[([[https://www.cmaj.ca/content/186/8/E295|Day, G. S., & Del Campo, C. M. (2014). Wernicke encephalopathy: a medical emergency. Cmaj, 186(8), E295-E295.]])] | ||
+ | ===== Terminology ==== | ||
+ | Classically, Wernicke encephalopathy is an acute presentation, while Korsakoff syndrome is a late, chronic manifestation of Wernicke encephalopathy that typically presents as anterograde and retrograde amnesia with preserved long-term memory. | ||
+ | |||
+ | <panel type="info" title="Wernicke vs. Korsakoff" footer="* = Cannot occur during an acute delirium or dementia and must persist beyond usual duration of intoxication or withdrawal management" no-body="true"> | ||
+ | <mobiletable 1> | ||
+ | ^ ^ Course ^ Symptoms ^ | ||
+ | ^ Wernicke Encephalopathy (WE) | Acute, but reversible | The classic triad of: \\ • Eye abnormalities (nystagmus, oculomotor paralysis, paralysis of conjugate gaze), CN VI palsy AKA lateral gaze palsy (lateral rectus) \\ • Ataxia of stance and gait \\ • Mental status changes, including withdrawal, confusion, retro/anterograde amnesia | | ||
+ | ^ Korsakoff's Syndrome/Amnesia (KS)* | Chronic and only 20% of cases are reversible with treatment | • Anterograde amnesia \\ • Confabulations\\ • Personality changes | | ||
+ | </mobiletable> | ||
+ | </panel> | ||
+ | ===== Pathophysiology ===== | ||
+ | <alert type="info" icon="fa fa-book fa-lg fa-fw"> | ||
+ | See also: **[[https://pubmed.ncbi.nlm.nih.gov/16384871/|Thomson, A. D., & Marshall, E. J. (2006). The natural history and pathophysiology of Wernicke's encephalopathy and Korsakoff's psychosis. Alcohol and Alcoholism, 41(2), 151-158.]]** | ||
+ | </alert> | ||
+ | |||
+ | ==== Thiamine Absorption and Storage ==== | ||
+ | * The daily thiamine requirement for healthy individuals is between 1 and 2 mg per day, and is related to overall carbohydrate intake. | ||
+ | * The thiamine requirement increases with alcohol misuse. | ||
+ | * There are several mechanisms behind this, including inadequate dietary intake, malabsorption of thiamine from the gastrointestinal tract due to alcohol’s effects, and impaired utilization of thiamine in the cells. | ||
+ | * Since the body stores are only between 30 and 50 mg of thiamine, it is estimated that this store is depleted in 4–6 weeks.[([[https://pubmed.ncbi.nlm.nih.gov/16384871/|Thomson, A. D., & Marshall, E. J. (2006). The natural history and pathophysiology of Wernicke's encephalopathy and Korsakoff's psychosis. Alcohol and Alcoholism, 41(2), 151-158.]])] | ||
+ | ==== Vitamin B1 (Thiamine) Deficiency ==== | ||
+ | <WRAP group> | ||
+ | <WRAP half column> | ||
+ | * Thiamine is a cofactor in the decarboxylation of pyruvate. Thiamine is needed for pyruvate to enter the citric acid cycle, which allows for aerobic metabolism of glucose to adenosine triphosphate (ATP). | ||
+ | * Lack of ATP production in areas of the brain susceptible to thiamine depletion thus leads to neuronal death | ||
+ | * This can result in damage to the limbic system, specifically the mammillary bodies and anterior/medial thalamus. | ||
+ | </WRAP> | ||
+ | |||
+ | <WRAP half column> | ||
+ | <callout type="tip" title="A Quick Review on Vitamins" icon="true"> | ||
+ | Vitamins are either water-soluble (vitamins B and C), or fat-soluble (vitamins A, D, E, K) | ||
+ | * **Fat-soluble vitamins** are dependent on absorption from the ileum and pancreas. Toxicity is easier with fat soluble vitamins because these vitamins accumulate in fat. Malabsorption syndromes such as cystic fibrosis and/or celiac disease) can result in fat-soluble vitamin deficiencies. | ||
+ | * **Water-soluble vitamins** are usually important coenzymes in cellular processes or precursors to coenzymes. All are excreted easily from the body, except for vitamins B12 and B9. B vitamin deficiency can result in glossitis, dermatitis, and diarrhea. For certain vitamin B deficiencies (B1 and B12), there can be neuropsychiatric and cognitive symptoms as well. Broadly, the B vitamins include: | ||
+ | * [[cl:wernicke-korsakoff|B1 (thiamine)]] | ||
+ | * B2 (riboflavin) | ||
+ | * B3 (niacin) | ||
+ | * B5 (pantothenic acid) | ||
+ | * [[meds:antidepressants:maoi:home#vitamin-b6-pyridoxine-deficiency|B6 (pyridoxine)]] | ||
+ | * B7 (biotin) | ||
+ | * B9 (folate) | ||
+ | * Is stored in the liver between 3 to 4 months | ||
+ | * [[cl:vitamin-b12-cyanocobalamin-deficiency|B12 (cobalamin)]] | ||
+ | * Is stored in the liver between 3 to 4 years | ||
+ | </callout> | ||
+ | </WRAP> | ||
+ | </WRAP> | ||
+ | |||
+ | ===== Differential Diagnosis ===== | ||
+ | * **Other medical issues resulting in thiamine deficiency** | ||
+ | * Although thiamine deficiency often occurs in the context of alcohol use disorders, it can also occur in eating disorders, malnutrition, hyperemesis gravidarum, chronic vomiting, extreme dieting, and cancer patients[([[https://pubmed.ncbi.nlm.nih.gov/23157990/|Isenberg-Grzeda, E., Kutner, H. E., & Nicolson, S. E. (2012). Wernicke-Korsakoff-syndrome: under-recognized and under-treated. Psychosomatics, 53(6), 507–516.]])] undergoing chemotherapy. | ||
+ | * **[[cl:1-delirium|Delirium]]** | ||
+ | * Confusion and memory impairment may be due to delirium | ||
+ | * **[[cl:tbi|Traumatic brain injury]]** | ||
+ | * There is a risk of the Wernicke being missed in patients with acute head injury. A history of alcohol use may not be available, and the signs and symptoms of Wernicke encephalopathy may be misattributed to the head injury.[([[https://pubmed.ncbi.nlm.nih.gov/9719389/|Cook, C. C., Hallwood, P. M., & Thomson, A. D. (1998). B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol and Alcoholism, 33(4), 317-336.]])] | ||
+ | * **[[addictions:alcohol:4-other|Alcohol-induced psychosis]]** | ||
+ | * **[[geri:dementia:home|Neurodegenerative disorders]]** | ||
+ | ===== Investigations ===== | ||
+ | * B12, thiamine (not all laboratories may have thiamine available) | ||
+ | * CBC, electrolytes, creatinine, GGT (indicator of acute liver injury from alcohol use, for individuals drinking > 4 drinks/day), AST, ALT, ALP, GGT | ||
+ | * Elevated AST/ALT ratio may be suggestive of alcoholic liver disease.[([[https://pubmed.ncbi.nlm.nih.gov/15208167/|Nyblom, H., Berggren, U., Balldin, J., & Olsson, R. (2004). High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol and alcoholism, 39(4), 336-339.]])] | ||
+ | * INR | ||
+ | |||
+ | |||
+ | ===== Physical Exam ===== | ||
+ | * Nystagmus and ophthalmoplegia are the most common ocular findings in Wernicke.[([[https://pubmed.ncbi.nlm.nih.gov/20642790/|Galvin, R., Bråthen, G., Ivashynka, A., Hillbom, M., Tanasescu, R., & Leone, M. A. (2010). EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European Journal of Neurology, 17(12), 1408-1418.]])] | ||
+ | * In patients with chronic alcohol use disorder with //only// an ataxic gait and stance found on physical exam, and no other neurological findings, they most likely have alcoholic cerebellar degeneration (midline cerebellar degeneration). | ||
+ | |||
+ | |||
+ | ==== Neuroimaging ==== | ||
+ | * [[neurology:mri|MRI]] brain may show mammillary body atrophy, volume loss in the thalamus, volume loss in the corpus callosum. | ||
+ | * Lesions from Wernicke are characterized by petechial hemorrhages and can be often found with a symmetrical distribution around the cerebral aqueduct, third ventricle, and fourth ventricle.[([[https://pubmed.ncbi.nlm.nih.gov/27799475/|Hattingen, E., Beyle, A., Müller, A., Klockgether, T., & Kornblum, C. (2016). Wernicke encephalopathy: SWI detects petechial hemorrhages in mammillary bodies in vivo. Neurology, 87(18), 1956-1957.]])] | ||
+ | * CT head are unfortunately poor at identifying mammillary body lesions and thus not recommended.[([[https://pubmed.ncbi.nlm.nih.gov/20642790/|Galvin, R., Bråthen, G., Ivashynka, A., Hillbom, M., Tanasescu, R., & Leone, M. A. (2010). EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. European Journal of Neurology, 17(12), 1408-1418.]])] | ||
+ | |||
+ | |||
+ | ===== Treatment ====== | ||
+ | <alert type="info" icon="fa fa-book fa-lg fa-fw"> | ||
+ | See also: | ||
+ | * **[[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578911/|Flynn, A. et al. (2015). Wernicke’s encephalopathy: increasing clinician awareness of this serious, enigmatic, yet treatable disease. The primary care companion for CNS disorders, 17(3).]]** | ||
+ | * **[[https://pubmed.ncbi.nlm.nih.gov/15746545/|Carota, A., & Schnider, A. (2005). Dramatic recovery from prolonged Wernicke-Korsakoff disease. European neurology, 53(1), 45-46.]]** | ||
+ | </alert> | ||
+ | |||
+ | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success"> | ||
+ | See also article: **[[addictions:alcohol:home]]** | ||
+ | </alert> | ||
+ | |||
+ | Thiamine resupplementation is the primary treatment. Oculomotor deficits should resolve over hours to days, while cognitive impairment may resolve within days to weeks. Most patients will exhibit some residual deficits.[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1031727/|Foster, J. B. (1989). The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition. Journal of Neurology, Neurosurgery, and Psychiatry, 52(10), 1217.]])] | ||
+ | |||
+ | |||
+ | ==== IV Thiamine ==== | ||
+ | * Treatment is with intravenous thiamine therapy, but the optimum dosage remains controversial.[([[https://pubmed.ncbi.nlm.nih.gov/17681641/|Donnino, M. W., Vega, J., Miller, J., & Walsh, M. (2007). Myths and misconceptions of Wernicke’s encephalopathy: what every emergency physician should know. Annals of emergency medicine, 50(6), 715-721.]])] Some clinicians base dosing from a study published by Cook et al. in 1998, which recommended up to 1 g of thiamine daily to achieve a clinical response.[([[https://pubmed.ncbi.nlm.nih.gov/9719389/|Cook, C. C., Hallwood, P. M., & Thomson, A. D. (1998). B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol and Alcoholism, 33(4), 317-336.]])][([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354137/|Nishimoto, A., Usery, J., Winton, J. C., & Twilla, J. (2017). High-dose parenteral thiamine in treatment of Wernicke's encephalopathy: case series and review of the literature. in vivo, 31(1), 121-124.]])][([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545191/|Thomson, A. D., Guerrini, I., & Marshall, E. J. (2012). The evolution and treatment of Korsakoff's syndrome. Neuropsychology review, 22(2), 81-92.]])] | ||
+ | * In individuals with suspected clinical signs of Wernicke, they should be prescribed thiamine 500mg IV x 3 days (some may prescribe as high as 500mg TID), followed by 250mg IV x 3 days (some may prescribe as high as 250mg TID) followed by oral supplementation 100mg PO daily.[([[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545191/|Thomson, A. D., Guerrini, I., & Marshall, E. J. (2012). The evolution and treatment of Korsakoff's syndrome. Neuropsychology review, 22(2), 81-92.]])] | ||
+ | * A significant improvement in neurologic symptoms or cognitive function helps confirm the diagnosis. | ||
+ | * Most patients should thereafter have indefinite oral thiamine supplementation (i.e. - 100 mg thiamine daily) until there is resolution of their nutritional compromise.[([[https://pubmed.ncbi.nlm.nih.gov/17681641/|Donnino, M. W., Vega, J., Miller, J., & Walsh, M. (2007). Myths and misconceptions of Wernicke’s encephalopathy: what every emergency physician should know. Annals of emergency medicine, 50(6), 715-721.]])] | ||
+ | |||
+ | |||
+ | ==== Oral Thiamine ==== | ||
+ | * Remember that oral thiamine is difficult to absorb, so even for individuals with adequate oral intake, IV administration is recommended. In individuals with gut absorption changes (e.g. - bariatric surgery), IV supplementation is a must. | ||
+ | * It could also be argued that in general, the oral doses of thiamine are so low, and that is that it would provide a negligible effect on symptoms. | ||
+ | * In situations where IV thiamine is not available, thiamine 300mg PO TID could be prescribed. | ||
+ | * In low risk patients, thiamine 100mg TID should be prescribed as ongoing supplementary therapy in alcohol use disorder patients identified as at risk for thiamine deficiency.[([[http://rebelem.com/should-you-prescribe-oral-thiamine-for-chronic-alcoholics/|RebelEM:Should You Prescribe Oral Thiamine for Chronic Alcoholics?]])] | ||
+ | |||
+ | |||
+ | ===== Guidelines ===== | ||
+ | <alert icon="fa fa-arrow-circle-right fa-lg fa-fw" type="success"> | ||
+ | See also: **[[teaching:clinical-practice-guidelines-cpg|]]** | ||
+ | </alert> | ||
+ | |||
+ | {{page>teaching:clinical-practice-guidelines-cpg#wernicke-encephalopathy&nouser&noheader&nodate&nofooter}} | ||
+ | |||
+ | ===== Resources ===== | ||
+ | * [[https://www.emra.org/emresident/article/wernicke/|EM Resident: Detecting Wernicke-Korsakoff Syndrome]] | ||
+ | * [[https://www.cmaj.ca/content/186/8/E295|Day, G. S., & Del Campo, C. M. (2014). Wernicke encephalopathy: a medical emergency. Cmaj, 186(8), E295-E295.]] | ||
+ | * [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545191/|Thomson, A. D., Guerrini, I., & Marshall, E. J. (2012). The evolution and treatment of Korsakoff's syndrome. Neuropsychology review, 22(2), 81-92.]] | ||
+ | * [[https://www.cochrane.org/CD004033/DEMENTIA_thiamine-for-prevention-and-treatment-of-wernicke-korsakoff-syndrome-in-people-who-abuse-alcohol|Day, E. et al. (2013). Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol. Cochrane Database of Systematic Reviews, (7).]] | ||
+ | |||